This article focuses on the concepts of ecosystems and clusters, with an emphasis on their
importance for building vibrant a vibrant and life science/biopharma industry. We illustrate …

We examine and analyze the elements important for developing a commercialization
strategy for an emerging technology of great relevance to biopharma: three-dimensional bio …

We note and reflect on the power of international partnering and collaborations that led to
many of the innovations that were brought to market extremely quickly and successfully …

Los Angeles brands itself as the “creative capital of the world.” While a leader in a variety of
innovative industries, this leadership has not extended to biotechnology, an entrepreneurial …

Developing solutions for biopharma/medtech/digital medicine products and services
requires a cross-disciplinary team to engage a broad section of the healthcare ecosystem …

Biotechnology (biotech) clusters have evolved over time. Being a top biotech region in the
early years 1978–1990 still positively correlates with the cluster's biotech strength decades …

Many cities and countries still view the foundation of a biotech sector as desirable for a high-
tech, intellectually driven economy. But a discussion by seasoned biotech management and …

The COVID-19 pandemic underscored the power of innovation in the biotech sector. Key to
the rapid development of a vaccine against the SARS-CoV2 virus was the immediate …

It is common opinion that Life sciences and particularly Biotech are an incredible opportunity
for growth. Start-ups and academic spin off are strategic assets that are at the core of the …

This article highlights the factors that drive successful collaborations and partnerships that
underlie accessing transformative technologies, and financially sharing of value created …